nitroglycerin has been researched along with natriuretic peptide, brain in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (5.66) | 18.2507 |
| 2000's | 33 (62.26) | 29.6817 |
| 2010's | 15 (28.30) | 24.3611 |
| 2020's | 2 (3.77) | 2.80 |
| Authors | Studies |
|---|---|
| Cosentino, F; Ganten, D; Mele, AF; Muscolo, M; Natale, A; Rubattu, S; Russo, R; Savoia, C; Vecchione, C; Volpe, M | 1 |
| Kamei, K; Kamijo, T; Kamiyama, T; Ohba, Y; Sudo, H; Sugo, I | 1 |
| Chatterjee, K; Chou, TM; DeMarco, T; Hutchison, SJ; Ko, E; Pothireddy, MR; Protter, AA; Sudhir, K; Zellner, C | 1 |
| Poole-Wilson, PA | 1 |
| Dunavant, S | 1 |
| Rifkin, W | 1 |
| Peacock, WF | 1 |
| Adams, KF; Gheorghiade, M; Mathur, VS | 1 |
| Mills, RM | 1 |
| Darko, W; Guharoy, R; Kelberman, M; Noviasky, JA; Whalen, KM | 1 |
| de Lemos, JA; Drazner, M; McGuire, DK | 1 |
| Emerman, CL | 1 |
| Akhter, MW; Elkayam, U; Khan, S; Singh, H; Usman, A | 1 |
| Emerman, CL; Peacock, WF; Young, J | 1 |
| Blann, AD; Chong, AY; Freestone, B; Hughes, E; Lip, GY; Patel, J | 1 |
| Massie, BM; Shlipak, MG | 1 |
| Alexander, KS; Fink, JM; Honisko, ME; Mauro, VF; Militello, MA | 1 |
| Saltzberg, MT | 1 |
| Abraham, WT; Adams, KF; Berkowitz, RL; Cheng, ML; Costanzo, MR; Fonarow, GC; LeJemtel, TH; Wynne, J | 1 |
| Dec, GW | 1 |
| Topol, EJ | 1 |
| Burger, AJ | 1 |
| Chen, JW; Ding, YA; Huang, PH; Leu, HB; Lin, SJ; Lu, TM; Wu, TC | 1 |
| Gheorghiade, M; O'Connor, CM; Stough, WG | 1 |
| Collins, SP; Hinckley, WR; Storrow, AB | 1 |
| Kakuchi, H; Kanzaki, H; Kitakaze, M; Maruo, T; Miyatake, K; Nakatani, S; Ohe, T; Yamagishi, M | 1 |
| Mehra, MR | 1 |
| Hollenberg, SM | 1 |
| De Berrazueta Fernández, JR | 1 |
| Anyadike, C; Scholz, PM; Tan, T; Weiss, HR; Zhang, Q | 1 |
| Arapi, S; Bistola, V; Farmakis, D; Filippatos, G; Karavidas, A; Korres, D; Kremastinos, DT; Matsakas, E; Paraskevaidis, IA; Parissis, JT | 1 |
| Chen, SM; Feng, XG; Li, P; Meng, SR; Wang, W; Xie, CL | 1 |
| Weeks, SG | 1 |
| Filippatos, G; Kirk, JD; Parissis, JT | 1 |
| Tan, T; Weiss, HR | 1 |
| Ang, DS; Lang, CC; Noman, A; Ogston, S; Struthers, AD | 1 |
| Coons, JC; McGraw, M; Murali, S | 1 |
| Chew, E; Chow, SL; Heywood, JT; O'Barr, SA; Pak, F; Patel, P; Patterson, JH; Peng, J; Quist, R | 2 |
| Ackerbauer, KA; Elkayam, U; Hshieh, S; Hyderi, AF; Ng, TM | 1 |
| Arrowsmith, JE; Valchanov, KP | 1 |
| Picker, O; Scheeren, TWL; Schober, P; Schwarte, LA; Schwartges, I | 1 |
| Sheikh-Taha, M; Zeitoun, A | 1 |
| Dong, L; Ge, J; Ge, L; Huang, D; Jin, H; Jin, X; Liu, Z; Ma, J; Qian, J; Wang, X; Yao, K; Zhang, F | 1 |
| Chowienczyk, P; Clapp, B; Fok, H; Jiang, B | 1 |
| Albert, NM; Butler, J; Carson, PE; Collins, SP; Colvin-Adams, M; Dimarco, JP; Ezekowitz, JA; Fang, JC; Givertz, MM; Hernandez, AF; Hershberger, RE; Katz, SD; Krishnamani, R; Rogers, JG; Spertus, JA; Starling, RC; Stevenson, WG; Stough, WG; Sweitzer, NK; Tang, WH; Teerlink, JR; Walsh, MN; Westlake Canary, CA | 1 |
| Gong, B; Li, Z; Wu, Z | 1 |
| Wang, Z; Zhang, S | 1 |
| Chen, XM; Fu, Y; Guo, JC; He, JY; Hua, Q; Li, J; Qin, J; Qin, S; Wang, Z; Yang, W; Zhan, H; Zhou, YJ | 1 |
| Asma, Z; Bel Haj Ali, K; Beltaief, K; Ben Brahim, N; Ben Soltane, H; Boubaker, H; Bouida, W; Bzeouich, N; Gannoun, I; Grissa, MH; Jeddi, C; Laouiti, K; Lotfi, B; Mariem, K; Msolli, MA; Nouira, S; Riadh, B; Rym, Y; Sekma, A; Trabelssi, I; Zied, M; Zohra, D | 1 |
| Chen, P; Jin, L; Luo, S; Mei, Z; Zhang, Q; Zhou, L; Zhu, C; Zhu, H | 1 |
19 review(s) available for nitroglycerin and natriuretic peptide, brain
| Article | Year |
|---|---|
Rapid optimization: strategies for optimal care of decompensated congestive heart-failure patients in the emergency department.
Topics: Atrial Natriuretic Factor; Decision Trees; Diuretics; Emergency Treatment; Heart Failure; Humans; Length of Stay; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; United States | 2002 |
B-type natriuretic peptide: from bench to bedside.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Cardiotonic Agents; Diuretics; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Randomized Controlled Trials as Topic; Receptors, Atrial Natriuretic Factor; Vasodilator Agents | 2003 |
The failing heart and the hemodynamic response to vasodilator therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Decision Making; Heart Failure; Hemodynamics; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Treatment Outcome; Vasodilator Agents | 2003 |
Science or fiction: use of nesiritide as a first-line agent?
Topics: Acute Disease; Health Care Costs; Heart Failure; Humans; Natriuretic Peptide, Brain; Nitroglycerin; Survival Rate; Treatment Outcome | 2003 |
Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department.
Topics: Decision Trees; Diuretics; Dopamine; Emergency Service, Hospital; Emergency Treatment; Heart Failure; Humans; Length of Stay; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Oxygen Inhalation Therapy; Practice Guidelines as Topic; United States | 2003 |
Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
Topics: Cardiotonic Agents; Decision Trees; Emergency Treatment; Heart Failure; Humans; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Vasodilator Agents | 2004 |
Overview of current noninodilator therapies for acute heart failure syndromes.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Heart Failure; Humans; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Severity of Illness Index; Syndrome; Vasodilator Agents | 2005 |
Critical review and recommendations for nesiritide use in the emergency department.
Topics: Cardiotonic Agents; Emergency Service, Hospital; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Randomized Controlled Trials as Topic; Treatment Outcome; Vasodilator Agents; Ventricular Premature Complexes | 2005 |
Optimizing outcomes in the patient with acute decompensated heart failure.
Topics: Biomarkers; Cardiotonic Agents; Diuretics; Heart Failure; Hemodynamics; Humans; Hydrazones; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Pyridazines; Pyridines; Risk Assessment; Simendan; Tetrazoles; Therapeutics; Troponin; Vasodilator Agents; Ventricular Function, Left; Ventricular Pressure | 2006 |
Vasodilators in acute heart failure.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Heart Failure; Humans; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Treatment Outcome; Vasodilator Agents | 2007 |
[Chronic heart failure treatment in the year 2006].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Cardiotonic Agents; Clinical Trials as Topic; Defibrillators, Implantable; Diuretics; Female; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Male; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Nitroglycerin; Patient Selection; Prognosis; Vasodilator Agents | 2006 |
Nesiritide: the clinical experience.
Topics: Acute Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Treatment Outcome | 2008 |
Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Diuretics; Emergency Service, Hospital; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Vasodilator Agents | 2009 |
Pharmacotherapy for acute heart failure syndromes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Dobutamine; Heart Failure; Humans; Milrinone; Morphine; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Practice Guidelines as Topic; Vasodilator Agents | 2011 |
The role of venodilators in the perioperative management of heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Hydralazine; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Perioperative Care; Vasodilator Agents | 2012 |
Acute decompensated heart failure: update on new and emerging evidence and directions for future research.
Topics: Adrenomedullin; Atrial Natriuretic Factor; Biomarkers; Blood Pressure Monitoring, Ambulatory; Cardiotonic Agents; Clinical Trials as Topic; Diet, Sodium-Restricted; Diuretics; Dopamine; Dose-Response Relationship, Drug; Dyspnea; Glycopeptides; Heart Failure; Hemofiltration; Hospitalization; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Peptide Fragments; Prognosis; Protein Precursors; Quality of Health Care; Relaxin; Risk Assessment; Saline Solution, Hypertonic; Urea; Vasodilator Agents; Xanthines | 2013 |
Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials.
Topics: Heart Failure; Humans; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Nitroglycerin; Randomized Controlled Trials as Topic; Treatment Outcome; Vasodilator Agents | 2016 |
Effect of recombinant human brain natriuretic peptide (rhBNP) versus nitroglycerin in patients with heart failure: A systematic review and meta-analysis.
Topics: Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Randomized Controlled Trials as Topic; Recombinant Proteins | 2016 |
Efficacy of brain natriuretic peptide
Topics: Contrast Media; Creatinine; Humans; Kidney Diseases; Natriuretic Peptide, Brain; Network Meta-Analysis; Nicorandil; Nitroglycerin; Percutaneous Coronary Intervention | 2022 |
11 trial(s) available for nitroglycerin and natriuretic peptide, brain
| Article | Year |
|---|---|
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Topics: Analysis of Variance; Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Drug Therapy, Combination; Dyspnea; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Nitroglycerin; Prospective Studies; Pulmonary Wedge Pressure; Statistics, Nonparametric; Vasodilator Agents | 2002 |
Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure.
Topics: Cardiac Catheterization; Cross-Over Studies; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Prospective Studies; Pulmonary Wedge Pressure; Time Factors; Vasodilator Agents; Ventricular Function, Left | 2004 |
Nesiritide in congestive heart failure associated with acute coronary syndromes: a pilot study of safety and efficacy.
Topics: Acute Disease; Cardiac Catheterization; Coronary Disease; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nitroglycerin; Pilot Projects; Pulmonary Wedge Pressure; Retrospective Studies; Syndrome; Vasodilator Agents | 2004 |
[Comparison of the effects of intravenous recombinant human brain natriuretic peptide and nitroglycerin in patients with decompensated acute heart failure: a multicenter, randomized, open-label, parallel-design study].
Topics: Adolescent; Adult; Aged; Cardiotonic Agents; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nitroglycerin; Recombinant Proteins; Young Adult | 2006 |
Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure.
Topics: Aged; Chronic Disease; Endothelium, Vascular; Female; Heart Failure; Humans; Hydrazones; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Middle Aged; Natriuretic Peptide, Brain; Nitroglycerin; Pyridazines; Severity of Illness Index; Simendan; Solubility; Stroke Volume; Vascular Cell Adhesion Molecule-1; Vasodilation; Vasodilator Agents | 2008 |
[Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin].
Topics: Aged; Aged, 80 and over; Blood Pressure; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Nitric Oxide Donors; Nitroglycerin; Recombinant Proteins; Treatment Outcome | 2008 |
Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Angina Pectoris; Blood Pressure; C-Reactive Protein; Cardiovascular Agents; Chronic Disease; Cross-Over Studies; Double-Blind Method; Electrocardiography; Enzyme Inhibitors; Exercise Tolerance; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nitroglycerin; Placebos; Time Factors; Vasodilator Agents; Xanthine Oxidase; Young Adult | 2010 |
Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Female; Heart Failure; Humans; Infusions, Intravenous; Kidney; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Nitroglycerin; Prospective Studies | 2011 |
Modulation of novel cardiorenal and inflammatory biomarkers by intravenous nitroglycerin and nesiritide in acute decompensated heart failure: an exploratory study.
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cystatin C; Female; Glomerular Filtration Rate; Heart Failure; Humans; Infusions, Intravenous; Interleukin-6; Kidney; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Prospective Studies; Retrospective Studies; Transforming Growth Factor beta1; Treatment Outcome; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2011 |
REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER).
Topics: Aged; Coronary Circulation; Diltiazem; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nitroglycerin; Percutaneous Coronary Intervention; Prospective Studies; Treatment Outcome; Troponin T; Vasodilator Agents; Verapamil | 2012 |
Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial.
Topics: Acute Disease; Aged; Antihypertensive Agents; Blood Pressure; Cause of Death; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Hypertension; Injections, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Nitroglycerin; Peptide Fragments; Piperazines; Ventricular Function, Left | 2017 |
23 other study(ies) available for nitroglycerin and natriuretic peptide, brain
| Article | Year |
|---|---|
Impaired vasorelaxant responses to natriuretic peptides in the stroke-prone phenotype of spontaneously hypertensive rats.
Topics: Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Carotid Artery, Internal; Cerebrovascular Disorders; Cyclic GMP; Hypertension; In Vitro Techniques; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Nitroglycerin; Phenotype; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasodilation | 1998 |
Hemodynamic and hormonal responses to nicorandil in a canine model of acute ischemic heart failure: a comparison with cromakalim and nitroglycerin.
Topics: Acute Disease; Animals; Atrial Natriuretic Factor; Cardiac Output, Low; Cromakalim; Dogs; Embolization, Therapeutic; Female; Hemodynamics; Hormones; Male; Microspheres; Myocardial Ischemia; Natriuretic Peptide, Brain; Nicorandil; Nitroglycerin; Potassium Channels; Renin; Vasodilator Agents | 1999 |
Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries.
Topics: Animals; Coronary Vessels; Cyclooxygenase Inhibitors; Endothelin-1; Enzyme Inhibitors; Female; Glyburide; Indomethacin; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitroglycerin; Pericardium; Potassium Channel Blockers; Swine; Vascular Resistance; Vasodilation; Vasodilator Agents | 1999 |
Treatment of acute heart failure: out with the old, in with the new.
Topics: Acute Disease; Atrial Natriuretic Factor; Cardiotonic Agents; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Treatment Failure | 2002 |
Nesiritide vs nitroglycerin for decompensated congestive heart failure.
Topics: Cardiotonic Agents; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Vasodilator Agents | 2002 |
Nesiritide vs nitroglycerin for decompensated congestive heart failure.
Topics: Cardiotonic Agents; Data Interpretation, Statistical; Heart Failure; Hemodynamics; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Outcome Assessment, Health Care; Research Design; Vasodilator Agents | 2002 |
Nesiritide in acute heart failure.
Topics: Acute Disease; Cardiac Output, Low; Clinical Trials as Topic; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Research Design; Treatment Outcome | 2003 |
Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.
Topics: Aged; Biomarkers; Brachial Artery; Cell Count; Coronary Circulation; Endothelial Cells; Endothelium, Vascular; Female; Heart Failure; Hemorheology; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nitroglycerin; Thrombomodulin; Ultrasonography; Vasodilator Agents; von Willebrand Factor | 2004 |
The clinical challenge of cardiorenal syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Case Management; Cohort Studies; Creatinine; Disease Progression; Diuretics; Forecasting; Glomerular Filtration Rate; Heart Failure; Hospitalization; Humans; Kidney; Kidney Failure, Chronic; Natriuretic Peptide, Brain; Nitroglycerin; Randomized Controlled Trials as Topic; Renal Circulation; Syndrome | 2004 |
Compatibility of argatroban with selected cardiovascular agents.
Topics: Amiodarone; Anticoagulants; Arginine; Cardiovascular Agents; Drug Interactions; Drug Therapy, Combination; Fenoldopam; Furosemide; Humans; Infusions, Parenteral; Lidocaine; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Pipecolic Acids; Sulfonamides; Vasopressins | 2004 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Retrospective Studies | 2005 |
Acute decompensated heart failure: the shrinking role of inotropic therapy.
Topics: Acute Disease; Cardiovascular Agents; Dobutamine; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Treatment Outcome | 2005 |
Nesiritide - not verified.
Topics: Adverse Drug Reaction Reporting Systems; Drug Approval; Drug Costs; Drug Industry; Health Services Misuse; Heart Failure; Humans; Infusions, Intravenous; Marketing; Medicare; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Outcome Assessment, Health Care; Pulmonary Wedge Pressure; Research Design; United States; United States Food and Drug Administration; Vasodilator Agents | 2005 |
Risk of death with nesiritide.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Research Design | 2005 |
Comparison of endothelial vasodilator function, inflammatory markers, and N-terminal pro-brain natriuretic peptide in patients with or without chronotropic incompetence to exercise test.
Topics: Adult; Aged; Brachial Artery; C-Reactive Protein; Chemokine CCL2; Endothelium, Vascular; Exercise; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nitroglycerin; Peptide Fragments; Vasodilation | 2006 |
Circadian variation of endothelial function in idiopathic dilated cardiomyopathy.
Topics: Adult; Atrial Natriuretic Factor; Biomarkers; Blood Flow Velocity; Brachial Artery; Cardiomyopathy, Dilated; Case-Control Studies; Circadian Rhythm; Endothelium, Vascular; Female; Forearm; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nitroglycerin; Regional Blood Flow; Stroke Volume; Treatment Outcome; Vasodilation; Vasodilator Agents | 2006 |
Chronic nitrates blunt the effects of not only nitric oxide but also natriuretic peptides in cardiac myocytes.
Topics: Animals; Carbazoles; Cell Size; Cells, Cultured; Dose-Response Relationship, Drug; Guanylate Cyclase; Indoles; Myocytes, Cardiac; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Natriuretic Peptides; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Phosphorylation; Protein Kinase Inhibitors; Rabbits; S-Nitroso-N-Acetylpenicillamine; Tachyphylaxis | 2007 |
Hypoxia inducible factor-1 protects against nitrate tolerance and stunning in rabbit cardiac myocytes.
Topics: Animals; Calcium-Binding Proteins; Carbazoles; Cell Shape; Cyclic GMP-Dependent Protein Kinases; Deferoxamine; Drug Tolerance; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Models, Biological; Myocardial Contraction; Myocardial Stunning; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nitroglycerin; Phosphorylation; Protein Kinase Inhibitors; Rabbits; S-Nitroso-N-Acetylpenicillamine; Up-Regulation | 2010 |
Comparative effects of nesiritide and nitroglycerin on renal function, and incidence of renal injury by traditional and RIFLE criteria in acute heart failure.
Topics: Acute Disease; Acute Kidney Injury; Adult; Aged; Cohort Studies; Female; Heart Failure; Humans; Incidence; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Natriuretic Peptide, Brain; Nitroglycerin; Retrospective Studies; Risk Factors | 2012 |
The differential effects of recombinant brain natriuretic peptide, nitroglycerine and dihydralazine on systemic oxygen delivery and gastric mucosal microvascular oxygenation in dogs.
Topics: Animals; Antihypertensive Agents; Dihydralazine; Dogs; Female; Gastric Mucosa; Microcirculation; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Oxygen Consumption; Random Allocation; Vasodilator Agents | 2012 |
Effect of intermittent nesiritide administration on kidney function.
Topics: Acute Kidney Injury; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Natriuretic Peptide, Brain; Nitroglycerin | 2012 |
Regulation of vascular tone and pulse wave velocity in human muscular conduit arteries: selective effects of nitric oxide donors to dilate muscular arteries relative to resistance vessels.
Topics: Adrenergic alpha-Antagonists; Adult; Blood Flow Velocity; Blood Pressure; Brachial Artery; Forearm; Humans; Hydralazine; Male; Middle Aged; Muscle, Smooth, Vascular; Natriuretic Peptide, Brain; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; Phentolamine; Pulse Wave Analysis; Radial Artery; Vascular Resistance; Vasodilation; Vasodilator Agents; Verapamil; Young Adult | 2012 |
Value of nitroglycerin test in the diagnosis of heart failure in emergency department patients with undifferentiated dyspnea.
Topics: Acute Disease; Dyspnea; Emergency Service, Hospital; Heart Failure; Humans; Natriuretic Peptide, Brain; Nitroglycerin; Prospective Studies; Sensitivity and Specificity; Stroke Volume | 2021 |